TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
72.26
+1.13 (1.59%)
Jul 24, 2026, 4:00 PM EDT - Market closed
TransMedics Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 171.92 | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 |
Depreciation & Amortization | 32.91 | 27.19 | 19.76 | 8.18 | 3.48 | 1.82 |
Stock-Based Compensation | 37.86 | 36.86 | 33.22 | 19.79 | 10.32 | 6.88 |
Other Adjustments | 8.59 | -79.87 | 5.36 | 28.38 | 3.37 | 3.65 |
Change in Receivables | 51.56 | 13.95 | -34.31 | -33.82 | -21.68 | 0.84 |
Changes in Inventories | -13.62 | -7.72 | -8.35 | -28.09 | -8.02 | -4.89 |
Changes in Accounts Payable | 0.33 | -0.02 | -1.4 | 6.96 | -3.27 | 5.09 |
Changes in Accrued Expenses | 19.23 | 17.69 | 7.94 | 14.25 | 3.44 | 4.88 |
Changes in Unearned Revenue | 0.85 | 1.14 | -0.2 | 0.08 | - | 0.01 |
Changes in Other Operating Activities | -6.94 | -6.68 | -8.68 | -3.73 | 2.78 | -2.92 |
Operating Cash Flow | 220.23 | 192.84 | 48.8 | -13.03 | -45.82 | -28.86 |
Operating Cash Flow Growth | 345.96% | 295.14% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -68.87 | -59.25 | -129.74 | -151.85 | -11.91 | -3.52 |
Purchases of Intangible Assets | - | - | - | -27.21 | - | - |
Purchases of Investments | - | - | - | - | -10.5 | -72.02 |
Proceeds from Sale of Investments | - | - | - | - | 76.92 | 104.81 |
Cash Acquisitions | - | - | 0.44 | -14.89 | - | - |
Investing Cash Flow | -68.87 | -59.25 | -129.3 | -193.95 | 54.51 | 29.27 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 445.38 | 58.51 | - |
Long-Term Debt Repaid | - | - | - | - | -36.05 | - |
Net Long-Term Debt Issued (Repaid) | - | - | - | 445.38 | 22.46 | - |
Issuance of Common Stock | 17.87 | 17 | 22.87 | 7.11 | 145.47 | 1.39 |
Repurchase of Common Stock | - | -0.14 | - | - | - | - |
Net Common Stock Issued (Repurchased) | 17.87 | 16.86 | 22.87 | 7.11 | 145.47 | 1.39 |
Other Financing Activities | - | - | - | -52.07 | - | - |
Financing Cash Flow | 17.59 | 16.86 | 22.87 | 400.42 | 167.93 | 1.39 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.59 | 1.27 | -0.54 | 0.19 | -1.02 | -0.8 |
Net Cash Flow | 56.91 | 151.72 | -58.16 | 193.63 | 175.6 | 1 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 151.36 | 133.59 | -80.94 | -164.88 | -57.72 | -32.38 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | 23.80% | 22.06% | -18.33% | -68.24% | -61.76% | -107.01% |
Free Cash Flow Per Share | 3.82 | 3.30 | -2.30 | -5.07 | -1.95 | -1.17 |
Levered Free Cash Flow | 135.82 | 162.65 | -85.21 | 266.15 | -27.28 | -43.75 |
Unlevered Free Cash Flow | 145.65 | 164.53 | -83.51 | -181.16 | -45 | -39 |